Magnetic resonance imaging is a very effective method for revealing anatomical details of soft tissues. Contrast agents can help to make these images even clearer and allow physiological processes to be followed in real time.
Conventional gadolinium complexes currently used as MRI contrast agent cannot reveal anatomic structures. As reported in the journal Angewandte Chemie, Korean researchers led by Jung Hee Lee at Samsung Medical Center and Taeghwan Hyeon at Seoul National University have now developed a new MRI contrast agent using manganese oxide nanoparticles that produces images of the anatomic structures of mouse brain which are as clear as those obtained by histological examination .
Magnetic resonance images after injection of the manganese oxide nanoparticles gave a view into different areas of the mouse brains—in excellent resolution. “We have developed the first truly biocompatible MRI contrast agent for anatomical brain imaging,” Lee and Hyeon point out. “With this agent, we are able to get high-contrast views of the anatomical details of live mouse brain.” The researchers hope that their new contrast agent will allow better research and diagnosis of brain diseases involving the CNS (central nervous system), such as Alzheimer’s disease, Parkinson’s disease, strokes, and tumors.
Furthermore, the Korean team was able to attach antibodies to the manganese oxide nanoparticles. These antibodies recognize and specifically bind to receptors on the surface of breast cancer cells. In mouse brains with breast cancer metastases, the tumors were clearly highlighted by the antibody-coupled contrast agent. The same principle should allow other disease-related changes or physiological systems to be visualized by using the appropriate antibodies.
Author: Taeghwan Hyeon, Seoul National University (Korea), http://nanomat.snu.ac.kr/intro.htm
Title: Development of a T1 Contrast Agent for Magnetic Resonance Imaging Using MnO Nanoparticles
Angewandte Chemie International Edition, doi: 10.1002/anie.200604775
Taeghwan Hyeon | Source: Angewandte Chemie
Further information: nanomat.snu.ac.kr/intro.htm
pressroom.angewandte.org
Further Reports about: atomic structure > nanoparticles > Oxide
More articles from Life Sciences:
New cancer target for non-Hodgkin's lymphoma
24.11.2009 | New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
New hydrogen-storage method discovered
24.11.2009 | Carnegie Institution
Daycare may double TV time for young children
24.11.2009 | Studies and Analyses
Insomnia prevalent among cancer patients who receive chemotherapy
24.11.2009 | Studies and Analyses
24.11.2009 | Social Sciences
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News